0DYQ.LSE Cegedim S.A.
- Market cap
- EUR 166M
- P/E
- 5.2x
- P/B
- -
- ROE
- 7.7%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is 0DYQ.LSE undervalued?
Graham numberThe Graham number of Cegedim S.A. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cegedim S.A. fundamental analysis
No fundamental analysis for Cegedim S.A. yet.
Cegedim S.A. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cegedim S.A.
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare and B2B ecosystem in France, rest of Europe, the Middle East, Africa, and internationally. The company offers practice management, pharmacy management, healthcare center management, and MSP management software, as well as drug database and hosting of healthcare data for doctor, dentist, pharmacist, nurse, physiotherapist, podiatrist, speech therapist, midwife,…
Full company profileCegedim S.A. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cegedim S.A. annual financial statements
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 429M | 457M | 468M | 504M | 497M | 525M | 555M | 616M | 654M | 649M | 1.30B |
| Gross Profit | 121M | 130M | 123M | 114M | 105M | 96.7M | 99.7M | 256M | 125M | 49.7M | 103M |
| Operating Income | 14.3M | 25.8M | 29.6M | 34.7M | 38.0M | 35.9M | 23.5M | 29.8M | 37.6M | 36.6M | 71.2M |
| EBITDA | 35.1M | 58.5M | 57.1M | 78.0M | 81.4M | 104M | 95.0M | 95.3M | 90.3M | 122M | 240M |
| Net Income | -26.7M | 11.1M | 5.77M | 2.70M | 10.8M | 26.2M | 13.6M | -7.41M | -14.7M | 9.40M | 21.8M |
| EPS | -1.92 | 0.80 | 0.41 | 0.19 | 0.78 | 1.90 | 1.00 | -0.54 | -1.07 | 0.68 | 1.59 |
| Balance Sheet | |||||||||||
| Total Assets | 709M | 746M | 648M | 809M | 905M | 798M | 890M | 924M | 987M | 1.00B | 1.02B |
| Total Liabilities | 520M | 549M | 449M | 607M | 697M | 565M | 586M | 630M | 704M | 709M | 726M |
| Shareholders' Equity | 189M | 197M | 199M | 201M | 208M | 232M | 285M | 276M | 264M | 282M | 281M |
| Cash & Short-term Investments | 20.8M | 18.7M | 81.1M | 29.1M | 24.7M | 24.2M | 55.6M | 46.6M | 49.6M | 92.3M | 78.7M |
| Total Debt | 248M | 255M | 189M | 276M | 266M | 276M | 285M | 270M | 326M | 325M | 322M |
| Cash Flow | |||||||||||
| Operating Cash Flow | 27.6M | 68.4M | 124M | 25.9M | 107M | 91.9M | 86.5M | 97.9M | 98.6M | 144M | 201M |
| Capital Expenditure | 61.8M | 60.6M | 58.9M | 62.4M | 74.5M | 64.8M | 17.6M | 22.0M | 31.3M | 24.1M | 88.3M |
| Free Cash Flow | -34.3M | 7.76M | 65.0M | -36.5M | 32.6M | 27.2M | 68.9M | 76.0M | 67.3M | 120M | 113M |
| Ratios | |||||||||||
| ROE | -14.2% | 5.6% | 2.9% | 1.3% | 5.2% | 11.3% | 4.8% | -2.7% | -5.6% | 3.3% | 7.7% |
| ROA | -3.8% | 1.5% | 0.9% | 0.3% | 1.2% | 3.3% | 1.5% | -0.8% | -1.5% | 0.9% | 2.1% |
| Net Profit Margin | -6.2% | 2.4% | 1.2% | 0.5% | 2.2% | 5.0% | 2.5% | -1.2% | -2.2% | 1.4% | 1.7% |
| Debt to Equity | 1.31x | 1.29x | 0.95x | 1.37x | 1.28x | 1.19x | 1.00x | 0.98x | 1.23x | 1.15x | 1.15x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cegedim S.A. dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | EUR 6.83M | 0.50 | 50.1% |
| 2021 | EUR 6.83M | 0.50 | 26.0% |
| 2020 | EUR 6.83M | 0.49 | 63.0% |
| 2019 | EUR 6.83M | 0.49 | 253.3% |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 690:589 on Nov 24, 2009.
Who owns Cegedim S.A.
- Insiders 60.88%
- Institutions 11.65%
- Public & others 27.47%
- Shares outstanding 13.9M
- Free float 5.22M
Cegedim S.A. company profile
- Company name
- Cegedim S.A.
- Ticker
- 0DYQ.LSE
- ISIN
- FR0000053506
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 6,492
- Fiscal year end
- December
- Address
- 137 rue d'Aguesseau, Boulogne-Billancourt, France, 92100
- Phone
- 33 1 49 09 22 00
- Website
- cegedim.com
About Cegedim S.A.
Cegedim SA operates as a technology and services company in the field of digital data flow management for healthcare and B2B ecosystem in France, rest of Europe, the Middle East, Africa, and internationally. The company offers practice management, pharmacy management, healthcare center management, and MSP management software, as well as drug database and hosting of healthcare data for doctor, dentist, pharmacist, nurse, physiotherapist, podiatrist, speech therapist, midwife, and administrator health center; and drug distribution statistics, digital promotion of non-REPS medication, point of sale promotion, and restocking drug solutions for marketing and ADV pharma. It also provides health and protection management and mandatory regime management software, healthcare insurer services, and healthcare insurance portals for insurer, mutual, welfare institute, broker, and delegate of management; and digitalization of invoices and processes, electronic signatures, archiving documents, EDI flows, supply management, and digital safe solutions for EDI manager, Digitization manager, DAF, CIO, and purchasing manager. In addition, the company offers payroll and HR management software, BPO, HR portal, payroll control, and time and activity management solution for payroll, HR manager, and training manager; and Data Hosting, IT infrastructure, integration of IT solutions, IT customer relationship management, digital promotion, IT service center, and back office outsourcing solutions for CIO, software editor, and start up. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SAS.
Cegedim S.A. management
10- Mr. Jean-Claude LabruneFounder, Chairman & CEO
- Ms. Sandrine DebroiseGroup CFO & Director
- Ms. Aude Labrune-MarysseDirector of Group Communications & Director
- Mr. Pierre MarucchiDeputy MD & Director
- Mr. Laurent Labrune-MarysseMD & Director
- Ms. Catherine AbivenPresident of Insurance Solutions & Director
- Frédéric le GuillouChief Information Officer
- Christelle VivetGeneral Counsel & Group Legal Director
- Anne-Louise SenneDirector of Group Human Resources
- Mr. David SyrManaging Director of GERS Data